A role for macrophages in erythropoiesis was suggested several decades ago when erythroblastic islands in the bone marrow, composed of a central macrophage surrounded by developing erythroblasts, were described. However, the in vivo role of macrophages in erythropoiesis under homeostatic conditions or in disease remains unclear. We found that specific depletion of CD169+ macrophages markedly reduced the number of erythroblasts in the bone marrow but did not result in overt anemia under homeostatic conditions, probably because of concomitant alterations in red blood cell clearance. However, CD169+ macrophage depletion significantly impaired erythropoietic recovery from hemolytic anemia, acute blood loss and myeloablation. Furthermore, macrophage depletion normalized the erythroid compartment in a JAK2V617F-driven mouse model of polycythemia vera, suggesting that erythropoiesis in polycythemia vera remains under the control of macrophages in the bone marrow and splenic microenvironments. These results indicate that CD169+ macrophages promote late erythroid maturation and that modulation of the macrophage compartment may be a new strategy to treat erythropoietic disorders.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Bessis, M. L'îlot érythroblastique, unité fonctionnelle de la moelle osseuse. Rev. Hematol. 13, 8–11 (1958).
Mohandas, N. & Prenant, M. Three-dimensional model of bone marrow. Blood 51, 633–643 (1978).
Lee, G. et al. Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formation. Blood 108, 2064–2071 (2006).
Rhodes, M.M., Kopsombut, P., Bondurant, M.C., Price, J.O. & Koury, M.J. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood 111, 1700–1708 (2008).
Hanspal, M., Smockova, Y. & Uong, Q. Molecular identification and functional characterization of a novel protein that mediates the attachment of erythroblasts to macrophages. Blood 92, 2940–2950 (1998).
Chasis, J.A. & Mohandas, N. Erythroblastic islands: niches for erythropoiesis. Blood 112, 470–478 (2008).
Chow, A. et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261–271 (2011).
Chow, A., Brown, B.D. & Merad, M. Studying the mononuclear phagocyte system in the molecular age. Nat. Rev. Immunol. 11, 788–798 (2011).
Miyake, Y. et al. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117, 2268–2278 (2007).
Crocker, P.R., Werb, Z., Gordon, S. & Bainton, D.F. Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macrophage-hematopoietic cell clusters. Blood 76, 1131–1138 (1990).
Manwani, D. & Bieker, J.J. The erythroblastic island. Curr. Top. Dev. Biol. 82, 23–53 (2008).
Barbé, E., Huitinga, I., Dopp, E.A., Bauer, J. & Dijkstra, C.D. A novel bone marrow frozen section assay for studying hematopoietic interactions in situ: the role of stromal bone marrow macrophages in erythroblast binding. J. Cell Sci. 109, 2937–2945 (1996).
Ramos, P. et al. Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis. Blood 117, 1379–1389 (2011).
Schroit, A.J., Madsen, J.W. & Tanaka, Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J. Biol. Chem. 260, 5131–5138 (1985).
Sadahira, Y. et al. Impaired splenic erythropoiesis in phlebotomized mice injected with CL2MDP-liposome: an experimental model for studying the role of stromal macrophages in erythropoiesis. J. Leukoc. Biol. 68, 464–470 (2000).
Cairo, G., Recalcati, S., Mantovani, A. & Locati, M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol. 32, 241–247 (2011).
Zhang, Z. et al. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood 118, 1912–1922 (2011).
Harandi, O.F., Hedge, S., Wu, D.C., McKeone, D. & Paulson, R.F. Murine erythroid short-term radioprotection requires a BMP4-dependent, self-renewing population of stress erythroid progenitors. J. Clin. Invest. 120, 4507–4519 (2010).
Paulson, R.F., Shi, L. & Wu, D.C. Stress erythropoiesis: new signals and new stress progenitor cells. Curr. Opin. Hematol. 18, 139–145 (2011).
Hashimoto, D. et al. Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. J. Exp. Med. 208, 1069–1082 (2011).
Sadahira, Y., Mori, M. & Kimoto, T. Participation of radioresistant Forssman antigen-bearing macrophages in the formation of stromal elements of erythroid spleen colonies. Br. J. Haematol. 71, 469–474 (1989).
Millot, S. et al. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. Blood 116, 6072–6081 (2010).
Sadahira, Y., Yoshino, T. & Monobe, Y. Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands. J. Exp. Med. 181, 411–415 (1995).
Kohyama, M. et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 457, 318–321 (2009).
Gooi, H.C. et al. Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3-fucosyl-N-acetyllactosamine. Eur. J. Immunol. 13, 306–312 (1983).
Tippett, E. et al. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals. PLoS ONE 6, e19968 (2011).
Xing, S. et al. Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice. Blood 111, 5109–5117 (2008).
Tefferi, A. et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110, 1092–1097 (2007).
Scott, L.M., Priestley, G.V. & Papayannopoulou, T. Deletion of α4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol. Cell. Biol. 23, 9349–9360 (2003).
Ulyanova, T., Jiang, Y., Padilla, S., Nakamoto, B. & Papayannopoulou, T. Combinatorial and distinct roles of α and α integrins in stress erythropoiesis in mice. Blood 117, 975–985 (2011).
Bungartz, G. et al. Adult murine hematopoiesis can proceed without β1 and β7 integrins. Blood 108, 1857–1864 (2006).
Thiele, J. et al. Macrophages and their subpopulations following allogenic bone marrow transplantation for chronic myeloid leukaemia. Virchows Arch. 437, 160–166 (2000).
Thiele, J. et al. Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation. Leukemia 14, 1378–1385 (2000).
Hartnell, A. et al. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97, 288–296 (2001).
Lenox, L.E., Perry, J.M. & Paulson, R.F. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood 105, 2741–2748 (2005).
Coleman, D.L., Russell, E.S. & Levin, E.Y. Enzymatic studies of the hemopoietic defect in flexed mice. Genetics 61, 631–642 (1969).
Seggewiss, R. & Einsele, H. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation. Semin. Hematol. 44, 203–211 (2007).
Miller, C.B. et al. Impaired erythropoietin response to anemia after bone marrow transplantation. Blood 80, 2677–2682 (1992).
Heuser, M. & Ganser, A. Recombinant human erythropoietin in the treatment of nonrenal anemia. Ann. Hematol. 85, 69–78 (2006).
Zhan, H. & Spivak, J.L. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era. Clin. Adv. Hematol. Oncol. 7, 334–342 (2009).
Reddy, M.M., Deshpande, A. & Sattler, M. Targeting JAK2 in the therapy of myeloproliferative neoplasms. Expert Opin. Ther. Targets 16, 313–324 (2012).
Hume, D.A. & MacDonald, K.P. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 119, 1810–1820 (2012).
Ramos, P. et al. Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia. Nat. Med. advance online publication, doi:10.1038/nm.3126 (17 March 2013).
Saito, M. et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19, 746–750 (2001).
Chen, K. et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc. Natl. Acad. Sci. USA 106, 17413–17418 (2009).
Reeves, J.P., Reeves, P.A. & Chin, L.T. Survival surgery: removal of the spleen or thymus. Curr. Protoc. Immunol. 2, 1.10 (2001).
Hoffmann-Fezer, G. et al. Biotin labeling as an alternative nonradioactive approach to determination of red cell survival. Ann. Hematol. 67, 81–87 (1993).
We thank C. Prophete, N. Dholakia, the Mount Sinai School of Medicine (MSSM) Microscopy Shared Resource Facility, J. Qi and S. Kim-Schulze at the MSSM Human Immune Monitoring Center, J. Ochando and X. Qiao at the MSSM Flow Cytometry Shared Resource Center and L. Tesfa at the Albert Einstein College of Medicine Flow Cytometry Sorting Facility for providing reagents, technical assistance and guidance. This work was supported by US National Institutes of Health grants (R01 grants HL097700, HL069438 and DK056638 to P.S.F., R01CA112100 to M.M. and R01HL116340 to P.S.F. and M.M.). A.C., J.A., D.L. and Y.K. were supported by fellowships from the National Heart, Lung and Blood Institute (5F30HL099028, A.C.), the National Institute of General Medical Sciences (T32GM062754, J.A.), Fundación Ramón Areces (D.L.) and the Japan Society for the Promotion of Science (Y.K.).
The authors declare no competing financial interests.
About this article
Cite this article
Chow, A., Huggins, M., Ahmed, J. et al. CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med 19, 429–436 (2013). https://doi.org/10.1038/nm.3057
Scientific Reports (2021)
Cancer and Metastasis Reviews (2021)
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives
Breast Cancer (2021)
Fisetin alleviates sepsis-induced multiple organ dysfunction in mice via inhibiting p38 MAPK/MK2 signaling
Acta Pharmacologica Sinica (2020)